13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001779763
Total reported value
$874.7M
$874.7M
22 檔
43.0%
At the close of Q4 2024, Iron Triangle Partners LP disclosed equity holdings valued at approximately $874.7M, spread across 22 reported holdings.
During Q4 2024, Iron Triangle Partners LP's portfolio maintained high stability with no major positional turnover, reflecting a continuous long-term holding approach.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | UNH | Unitedhealth Group Inc | Stock-Healthcare | 12.29% | +2.65% | NEW | |
| 2 | A | Agilent Technologies Inc | Stock-Healthcare | 8.82% | — | — | |
| 3 | GMED | Globus Medical Inc - A | Stock-Healthcare | 7.68% | — | — | |
| 4 | ABBV | Abbvie Inc | Stock-Healthcare | 7.32% | -6.60% | EXIT | |
| 5 | TEVA | Teva Pharmaceutical-sp Adr | Stock-Healthcare | 5.34% | — | +13.18% | |
| 6 | BSX | Boston Scientific CORP | Stock-Healthcare | 4.87% | +4.59% | NEW | |
| 7 | NBIX | Neurocrine Biosciences Inc | Stock-Healthcare | 4.78% | -2.62% | EXIT | |
| 8 | NVST | Envista Holdings CORP | Stock-Healthcare | 4.67% | +2.95% | NEW | |
| 9 | PODD | Insulet CORP | Stock-Healthcare | 4.43% | — | +40.01% | |
| 10 | MMSI | Merit Medical Systems Inc | Stock-Healthcare | 4.33% | +3.89% | NEW | |
| 11 | ISRG | Intuitive Surgical Inc | Stock-Healthcare | 4.31% | +6.12% | NEW | |
| 12 | DVA | Davita Inc | Stock-Healthcare | 4.29% | — | — | |
| 13 | EXK | Exact Sciences CORP | Stock-Materials | 3.71% | -3.89% | EXIT | |
| 14 | HQY | Healthequity Inc | Stock-Healthcare | 3.54% | — | — | |
| 15 | MEDP | Medpace Holdings Inc | Stock-Healthcare | 3.29% | — | -53.33% | |
| 16 | TWST | Twist Bioscience CORP | Stock-Other | 2.52% | — | -3.44% | |
| 17 | XBI | Ss Spdr S&p Biotech ETF | ETF-Tech | 2.48% | — | — | |
| 18 | GKOS | Glaukos CORP | Stock-Healthcare | 2.48% | -3.98% | EXIT | |
| 19 | CAH | Cardinal Health Inc | Stock-Healthcare | 2.42% | -3.08% | EXIT | |
| 20 | ARGX | Argenx Se - Adr | Stock-Healthcare | 2.37% | -1.04% | EXIT | |
| 21 | WAY | Waystar Holding CORP | Stock-Other | 2.23% | — | — | |
| 22 | DOCS | Doximity Inc-class A | Stock-Healthcare | 1.84% | +1.30% | — |
According to official SEC Form 13F filings, Iron Triangle Partners LP reported a total U.S. public equity portfolio value of $874.7M across 22 disclosed positions in Q4 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including UNH, A, GMED) accounted for 43.0% of total reported equity market value during Q4 2024.
During Q4 2024, Iron Triangle Partners LP's top holdings by market value included UNH (12.3%)、A (8.8%)、GMED (7.7%). The largest single position, UNH, represented 12.3% of total portfolio value.
In Q4 2024, Iron Triangle Partners LP made 0 total portfolio adjustments, initiating 0 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.